Iván Hernández Dalas: EndoQuest Robotics completes first robotic ESD procedure at Mayo Clinic

EndoQuest Robotics' Flexible Robotic Surgical System.

EndoQuest said its PARADIGM surgical system offers flexibility, advanced instrumentation, and an ergonomic design. | Source: EndoQuest Robotics

EndoQuest Robotics Inc. said a surgeon at the Mayo Clinic has successfully completed a robotic procedure as part of its Prospective Assessment of a Robotic Assisted Device in Gastrointestinal Medicine, or PARADIGM, Trial. The trial is a multicenter study intended to evaluate the company’s Endoluminal Surgical System for use in lower gastrointestinal track procedures.

Dr. Norio Fukami successfully completed an endoscopic submucosal dissection (ESD) using the Endoluminal Surgical (ELS) System to remove a complex colorectal lesion measuring 4 cm (1.5 in.) in size. He is a professor of medicine and director of Therapeutic Endoscopy and Interventional Gastrointestinal (GI) Endoscopy Fellowship at Mayo Clinic in Arizona. Fukami performed the ESD procedure as part of a U.S. Food and Drug Administration (FDA) Investigational Device Exemption (IDE) pivotal trial.

“The device was instinctive and easy to use, enabling dynamic traction and counter-traction of surgical technique, and made a complex procedure that would traditionally be much more challenging feel relatively straightforward,” said Dr. Fukami.

“This technology represents a monumental shift in our ability to perform ESD and other advanced endoluminal therapies,” he added. “For the first time, we’re equipped with a true surgeon’s ‘second hand’ that makes these procedures more natural and reproducible, with the potential to significantly reduce patients’ and physicians’ burden.”

EndoQuest said that Fukami is a world-renowned expert in ESD and other endoluminal and pancreaticobiliary techniques. He was also an editor for the first English textbook on ESD.

EndoQuest hopes to help patients avoid invasive procedures

ESD has emerged as an effective treatment option for early lesions in the GI tract. It has enabled many patients to avoid invasive surgeries such as colectomies, said EndoQuest.

Despite these benefits, ESD and other advanced endoluminal therapies are technically challenging with steep learning curves, the Houston company acknowledged. This is due in large part to the inherent limitations of standard flexible endoscopes and instrumentation, it noted.

EndoQuest said it designed its system to make advanced endoluminal procedures easier to learn and perform. The ELS System enables surgical tasks and maneuvers not currently possible in advanced therapeutic endoscopy, the company asserted.

Pre-clinical data presented by Brigham and Women’s Hospital at Digestive Disease Week (DDW) in 2024 and 2025 demonstrated that the ELS System significantly reduces the learning curve compared to conventional techniques for ESD and full-thickness defect closure among novice gastroenterologists.

“Therapeutic endoscopy represents one of the fastest-growing areas within medicine,” stated Dr. Todd Wilson, chief medical officer and chairman of the International Advisory Board of EndoQuest Robotics. “With a greater than 50% increase in the number of advanced endoscopy fellowship programs over the past decade, there is clearly a growing interest in advancing endoluminal, organ-sparing care, and our technology is positioned to drive this therapeutic shift.”

PARADIGM Trial to continue across the U.S.

The PARADIGM Trial is enrolling 50 subjects across five leading U.S. healthcare institutions: Brigham and Women’s Hospital in Boston; Mayo Clinic in Scottsdale, Ariz.; Cleveland Clinic in Cleveland; AdventHealth in Orlando, Fla.; and HCA Healthcare in Houston. Following trial completion, EndoQuest Robotics plans to submit a De Novo request for authorization to market the ELS System in the U.S.

In July, EndoQuest closed a Series D-2 funding round. The company said the funding will fuel the advancement of its flexible endoluminal surgical platform, supporting the PARADIGM clinical trial.

EndoQuest said its ELS System is an investigational device, has not yet been fully cleared by the FDA, and is not yet available for commercial sale in the U.S.

Editor’s note: Iman Jeddi, senior vice president and general manager at Intuitive Surgical, will deliver a keynote at RoboBusiness 2025, which will be on Oct. 15 and 16 in Santa Clara, Calif. She will discuss the design and launch of the da Vinci 5 surgical robot.

RoboBusiness will be co-located with DeviceTalks West, the premier industry event for medical technology professionals. Register now to attend.

SITE AD for the 2025 RoboBusiness registration open.

The post EndoQuest Robotics completes first robotic ESD procedure at Mayo Clinic appeared first on The Robot Report.



View Source

Popular posts from this blog

Iván Hernández Dalas: 4 Show Floor Takeaways from CES 2019: Robots and Drones, Oh My!

Image
We’ve had some time to recuperate from the madness of CES, in which more than 150,000 attendees and thousands of exhibitors displayed their latest gadgets, gizmos and yes, even robots, on the CES show floor. Last week’s reporter’s notebook focused on the collection of startups around the Eureka Park area of CES, but several of the same trends were evident on the main South Hall 2 area of the Las Vegas Convention Center, where drones, robotics, AR/VR, and gaming took center stage. While most of our time was spent at CES hosting the Service Robots Arrive in Daily Life event, we did have some time during the week to visit the show floor and record observations. Here’s what we saw on the show floor, as well as some of our own individual meetings: 1. Underwater drones make a big splash On the main floor, there was no busier aerial drone booth than the DJI booth, but that is expected given the company’s dominance in the space. But once you got past that, you noticed a lot more drone co...
Read more

[Ivan Hernandez Dalas] Mechatronics in Ghost in the Shell

Image
Adam Savage Behind the Scenes of Ghost in the Shell The acclaimed Ghost in the Shell portrayed serious advancements in technology and mechatronics, 20 years later we'll have a live action movie bringing all those elements to life. The acclaimed Ghost in the Shell (1995 Production: I.G, Bandai Visual, Kodansha and Manga Entertainment) portrayed serious advancements in technology and mechatronics, 20 years later we'll have a live action movie bringing all those elements to life. Animatronics, 3D printing, Castings, engineering, and art  will bring together this state of the art cyborgs  in a movie we can’t miss.  Tested´s Adam Savage  shows us -in a visit to Weta Workshops- how their team put together the  amazing and visually stunning  cyborgs for the movie. Adam Savage Behind the Scenes of Ghost in the Shell! Of course, let´s watch the trailer: "They created me, but they cannot control me." GHOST IN THE SHELL star...
Read more

Iván Hernández Dalas: Tacta Systems raises $75M to give robots a ‘smart nervous system’

Image
Tacta Systems said its technology enables robots to perform delicate, variable, human-like tasks with flexibility, efficiency, and autonomy. | Source: Adobe Stock Tacta Systems Inc., which is developing dexterous intelligence to give robots tactile skills and spatial awareness, last week raised $75 million. The Palo Alto, Calif.-based startup said it will use the funding to accelerate the development of systems capable of performing complex, human-like tasks. “Enabling machines to solve complex, physical world problems is the next frontier in robotics technology,” stated Andreas Bibl, co-founder and CEO of Tacta Systems. “AI models have become incredibly sophisticated in working with text and video, but much of the physical world remains incomprehensible to them,” he said. “We’re incredibly excited about the disruptive technology that we’re developing, which will ultimately help humanity automate much of the drudgery of factory work and grueling physical labor.” Tacta said its br...
Read more